As of 2024-07-27, the EV/EBITDA ratio of Amicus Therapeutics Inc (FOLD) is -48.29. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FOLD's latest enterprise value is 3,193.95 mil USD. FOLD's TTM EBITDA according to its financial statements is -66.15 mil USD. Dividing these 2 quantities gives us the above FOLD EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.1x - 25.7x | 20.1x |
| Forward P/E multiples | 19.9x - 25.2x | 23.7x |
| Fair Price | (5.06) - (6.24) | (5.49) |
| Upside | -149.7% - -161.2% | -154.0% |
| Date | EV/EBITDA |
| 2024-07-26 | -48.29 |
| 2024-07-25 | -48.64 |
| 2024-07-24 | -49.05 |
| 2024-07-23 | -48.87 |
| 2024-07-22 | -48.73 |
| 2024-07-19 | -49.18 |
| 2024-07-18 | -50.39 |
| 2024-07-17 | -50.17 |
| 2024-07-16 | -51.24 |
| 2024-07-15 | -50.30 |
| 2024-07-12 | -49.32 |
| 2024-07-11 | -49.67 |
| 2024-07-10 | -48.96 |
| 2024-07-09 | -48.87 |
| 2024-07-08 | -48.24 |
| 2024-07-05 | -47.57 |
| 2024-07-03 | -46.63 |
| 2024-07-02 | -46.81 |
| 2024-07-01 | -46.58 |
| 2024-06-28 | -47.12 |
| 2024-06-27 | -47.08 |
| 2024-06-26 | -46.14 |
| 2024-06-25 | -46.90 |
| 2024-06-24 | -47.48 |
| 2024-06-21 | -47.88 |
| 2024-06-20 | -46.58 |
| 2024-06-18 | -46.45 |
| 2024-06-17 | -47.66 |
| 2024-06-14 | -48.11 |
| 2024-06-13 | -50.37 |
| 2024-06-12 | -50.35 |
| 2024-06-11 | -49.27 |
| 2024-06-10 | -47.70 |
| 2024-06-07 | -47.70 |
| 2024-06-06 | -48.69 |
| 2024-06-05 | -49.63 |
| 2024-06-04 | -48.02 |
| 2024-06-03 | -47.61 |
| 2024-05-31 | -46.58 |
| 2024-05-30 | -46.94 |
| 2024-05-29 | -44.61 |
| 2024-05-28 | -45.60 |
| 2024-05-24 | -45.96 |
| 2024-05-23 | -45.11 |
| 2024-05-22 | -46.23 |
| 2024-05-21 | -47.08 |
| 2024-05-20 | -46.36 |
| 2024-05-17 | -45.55 |
| 2024-05-16 | -45.24 |
| 2024-05-15 | -45.96 |